Activation of AT2R and inhibition of AT1R may be a mechanism-specific approach to restore favorable vascular ang II responsiveness and improve microvascular function by reducing exaggerated AT1R-mediated vasoconstriction prior to the progression of clinical vascular disease in women who had preeclampsia. The gene discussed is AGTR1; the disease is preeclampsia.